Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $165.2400 (-2.62%) ($165.2400 - $165.2400) on Tue. Mar. 30, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.1% (three month average) | RSI | 60 | Latest Price | $165.2400(-2.62%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR advances 1.6% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) XLV(34%) VFMO(28%) VYM(28%) XBI(26%) IBB(25%) | Factors Impacting UTHR price | UTHR will decline at least -1.05% in a week (0% probabilities). VIXM(-21%) VXX(-15%) UUP(-12%) BND(-4%) TLT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.05% (StdDev 2.1%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $167.56(-1.38%) | 10 Day Moving Average | $168.28(-1.81%) | 20 Day Moving Average | $165.13(0.07%) | To recent high | -5.6% | To recent low | 11.1% | Market Cap | $7.33b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |